DE
68
5
TEL
69
3
AKAM
53
2
MCHP
54
13
CAT
64
2
UNH
63
4
PVH
67
5
HBI
55
-4
LEG
50
14
MHK
55
6
NWL
60
7
TAP
61
3
DGX
44
-6
GD
42
3
FMC
40
6
MMC
65
3
KLAC
56
9
IRM
50
3
TDC
83
3
PNR
71
2
DE
68
5
TEL
69
3
AKAM
53
2
MCHP
54
13
CAT
64
2
UNH
63
4
PVH
67
5
HBI
55
-4
LEG
50
14
MHK
55
6
NWL
60
7
TAP
61
3
DGX
44
-6
GD
42
3
FMC
40
6
MMC
65
3
KLAC
56
9
IRM
50
3
TDC
83
3
PNR
71
2
Financhill
Back

Aurinia Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
75

AUPH
Aurinia Pharmaceuticals

Last Price:
8.70
Seasonality Move:
24.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Aurinia Pharmaceuticals Price Quote

$8.70
-0.01 (-0.11%)
(Updated: November 26, 2024 at 5:55 PM ET)

Aurinia Pharmaceuticals Key Stats

Buy
75
Aurinia Pharmaceuticals (AUPH) is a Buy
Day range:
$8.69 - $9.00
52-week range:
$4.71 - $9.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.71
P/B ratio:
3.21%
Volume:
1.6M
Avg. volume:
1.3M
1-year change:
-5.02%
Market cap:
$1.2B
Revenue:
$175.5M
EPS:
$-0.14

How Much Does Aurinia Pharmaceuticals Make?

Is Aurinia Pharmaceuticals Growing As A Company?

Aurinia Pharmaceuticals Stock Price Performance

What Is Aurinia Pharmaceuticals 52-Week High & Low?

Aurinia Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Aurinia Pharmaceuticals?

Is Aurinia Pharmaceuticals Cash Flow Positive?

  • What Is AUPH Cash Flow From Operations?
    Cash flow from operations (TTM) is $28.6M
  • What Is Aurinia Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$31.6M
  • What Is Aurinia Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.2M

Aurinia Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AUPH return on invested capital is -5.99%
  • What Is Aurinia Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -4.19%
  • What Is AUPH Return On Equity?
    ROE is a measure of profitability and is -5.99%

Aurinia Pharmaceuticals Earnings Date & Stock Price

Aurinia Pharmaceuticals Competitors

Aurinia Pharmaceuticals Dividend Yield

Aurinia Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 566.67%
Revenue: 24.32% 17.47%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.84
Upside from Last Price: 24.41%

Major Shareholders

  • How many AUPH shares are owned by institutional investors?
    79.2M AUPH shares are owned by institutional investors
  • How many AUPH shares are owned by insiders?
    4.6M AUPH shares are owned by insiders